Yu Z, McNeill J H
Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Can J Physiol Pharmacol. 1991 Sep;69(9):1268-76. doi: 10.1139/y91-186.
Post-quiescent potentiation (PQP), an enhanced contraction following a long pause that occurs as a result of increased Ca2+ release from intracellular stores, and post-stimulation potentiation (PSP), an enhanced contraction following a rapid series of contractions that is believed to be related to increased Ca2+ influx, were measured in streptozotocin-treated Wistar, spontaneously hypertensive (SHR), and Wistar-Kyoto (WKY) diabetic heart tissues. Decreased PQP values were found in Wistar and SHR diabetic papillary muscles (PM) in comparison with the same strain controls, which suggests a diminished degree of releasable Ca2+ from sarcoplasmic reticulum (SR) in these tissues. Decreased PSP was found in SHR diabetic PM, which may be related primarily to a depressed sarcolemmal (SL) Na(+)-Ca2+ exchange in this tissue. PSP was not decreased in diabetic Wistar or WKY cardiac preparations, indicating that Ca2+ entry via channels must be involved in the PSP mechanism. Ryanodine depressed PQP in Wistar and SHR PM, and SHR left atria in both control and diabetic tissues. It abolished PQP and SHR diabetic tissues but had no effect on WKY control and diabetic tissues. The data suggest that the ryanodine effect differs in the various strains of rat. These differences may be due to differences in the SR sensitivity to ryanodine among the strains. Diabetic SR with impaired Ca2+ uptake may contribute to these phenomena. Ryanodine depressed PSP of Wistar and SHR diabetic PM but had no effects on tissues from controls. The influence of ryanodine on diabetic SL Na(+)-Ca2+ exchange requires further investigation.
在链脲佐菌素处理的Wistar大鼠、自发性高血压大鼠(SHR)和Wistar-Kyoto(WKY)大鼠的糖尿病心脏组织中,测量了静息后增强作用(PQP,即长时间暂停后因细胞内钙库释放钙增加而出现的收缩增强)和刺激后增强作用(PSP,即快速连续收缩后出现的收缩增强,据信与钙内流增加有关)。与相同品系的对照相比,在Wistar大鼠和SHR大鼠的糖尿病乳头肌(PM)中发现PQP值降低,这表明这些组织中肌浆网(SR)可释放钙的程度降低。在SHR大鼠的糖尿病PM中发现PSP降低,这可能主要与该组织中肌膜(SL)钠-钙交换受抑制有关。在糖尿病Wistar大鼠或WKY大鼠的心脏标本中PSP未降低,这表明通过通道的钙内流必定参与了PSP机制。在Wistar大鼠和SHR大鼠的PM以及SHR大鼠的左心房中,无论是对照组织还是糖尿病组织,ryanodine均降低了PQP。它消除了SHR糖尿病组织中的PQP,但对WKY对照组织和糖尿病组织没有影响。数据表明ryanodine的作用在不同品系的大鼠中有所不同。这些差异可能是由于各品系间SR对ryanodine的敏感性不同所致。钙摄取受损的糖尿病SR可能促成了这些现象。ryanodine降低了Wistar大鼠和SHR大鼠糖尿病PM的PSP,但对对照组织没有影响。ryanodine对糖尿病SL钠-钙交换的影响需要进一步研究。